6-K

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report ofForeign Private Issuer

Pursuant to Rule 13a-16 or15d-16

of the Securities Exchange Act of 1934

October 27, 2022

China LifeInsurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ___________

Commission File Number 001-31914

China Life Insurance Company Limited issued its 2022 Third Quarter Report on October 27, 2022, a copy of which is attached as Exhibit 99.1 hereto.

Certain statements contained in this announcement may be viewed as “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of the Company to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. Further information regarding these risks, uncertainties and other factors is included in the Company’s filings with the U.S. Securities and Exchange Commission, or SEC, on April 29, 2021 and in the Company’s other filings with the SEC. You should not place undue reliance on these forward-looking statements. All information provided in this announcement is as of the date of this announcement, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. Unless otherwise indicated, the Chinese insurance market information set forth in this announcement is based on public information released by the China Banking and Insurance Regulatory Commission.

EXHIBIT LIST

Exhibit	Description
99.1	2022 Third Quarter Report, dated October 27, 2022

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		China Life Insurance Company Limited
		(Registrant)
	By:	/s/ Zhao Peng
		(Signature)
October 27, 2022	Name:<br> <br>Title:	Zhao Peng<br> <br>President

EX-99.1

Commission File Number 001-31914

EXHIBIT 99.1

中國人壽保險股份有限公司

CHINA LIFE INSURANCE COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 2628)

2022THIRD QUARTER REPORT

This announcement is made by China Life Insurance Company Limited (the “Company”) pursuant to the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and Rules 13.09(2) and 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

IMPORTANT NOTICE

•	The Company’s Board of Directors, Board of Supervisors, its Directors, Supervisors and Senior Management<br>warrant that the information in the 2022 third quarter report is true, accurate and complete and contains no false representations, misleading statements or material omissions, and accept legal responsibility.
•	The financial data for the 2022 third quarter report of the Company have been prepared in accordance with the<br>China Accounting Standards for Business Enterprises and are unaudited. Net profit attributable to equity holders of the Company and equity attributable to equity holders of the Company in the consolidated financial statements have no difference from<br>the relevant data under the International Financial Reporting Standards.
---	---
•	Mr. Bai Tao, Chairman of the Board of the Company, Ms. Huang Xiumei, Vice President in charge of<br>financial affairs, Mr. Li Mingguang, Chief Actuary and Ms. Hu Jin, Head of the Financial Department, confirm that the financial statements in the 2022 third quarter report are true, accurate and complete.
---	---

• 1 -

1.	MAJOR FINANCIAL DATA
1.1	Major Accounting Data and Financial Indicators
---	---

Currency: RMB

Items	As at30September<br> <br>2022			As at 31 December 2021																Increase/(decrease)compared to31 December<br><br><br>2021
Total assets<br>(million)		5,128,085			4,891,085																4.8%
Equity attributable to equity holders of<br>the Company (million)		453,446			478,585																-5.3%
Items	For theReportingPeriod(from<br><br><br>July to<br><br><br>September)			For the correspondingperiod of 2021					Increase/(decrease)compared<br><br><br>to thecorresponding<br><br><br>period of 2021			Fortheninemonthsended 30September<br> <br>2022			For the correspondingperiod of 2021					Increase/(decrease)compared<br><br><br>to thecorresponding<br><br><br>period of 2021
			Afterrestatement			Beforerestatement		Afterrestatement			Afterrestatement			Afterrestatement			Beforerestatement		Afterrestatement
Operating income<br>(million)		172,714			175,136		175,110			-1.4%			701,012			727,785		727,711			-3.7%
Net profit attributable to equity holders<br>of the Company (million)		5,701			7,518		7,527			-24.2%			31,117			48,486		48,502			-35.8%
Net profit attributable to equity holders<br>of the Company after deducting non-recurring items (million)		5,735			7,578		7,587			-24.3%			31,182			48,651		48,667			-35.9%
Net cash flows from operating activities<br>(million)		N/A			N/A		N/A			N/A			288,755			246,373		246,388			17.2%
Earnings per share (basic and diluted)<br>(RMB per share)		0.20			0.27		0.27			-24.2%			1.10			1.72		1.72			-35.8%
Weighted average ROE (%)		1.22			1.60		1.60			A decrease<br>of 0.38<br>percentage<br><br><br>point			6.63			10.46		10.47			A decrease<br>of 3.83<br>percentage<br><br><br>points

Notes:

1.	The financial data for the first three quarters of 2021 in this report have been restated due to a business<br>combination under common control in 2021.
2.	In calculating the percentage change of “Earnings per share (basic and diluted)”, the tail<br>differences of the basic figures have been taken into account.
---	---

• 2 -

1.2	Non-recurring Items and Amounts

RMB million

Non-recurring items	For theReporting<br><br><br>Period(from July to<br><br><br>September)			For thenine monthsended30September<br> <br>2022
Gains/(losses) on<br>disposal of non-current assets		40			74
Government subsidies<br>recognized in current gains/(losses)		17			98
Net non-operating income and expenses other than those mentioned above		(100	)		(236	)
Effect of income<br>tax		11			16
Attributable to non-controlling interests		(2	)		(17	)
Total	****	(34	)	****	(65	)
Note:	The Company is an insurance company and investment (application of insurance fund) is one of its<br>major businesses. Therefore, the non-recurring items do not include fair value gains/(losses) from financial assets at fair value through profit or loss and financial liabilities at fair value through profit<br>or loss, as well as investment income from the disposal of financial assets at fair value through profit or loss and financial liabilities at fair value through profit or loss and<br>available-for-sale financial assets.
---	---

• 3 -

1.3	Particulars of and Reasons for Changes in Major Accounting Data and Financial Indicators

Currency: RMB

Items	For the nine monthsended 30 September2022	Forthecorrespondingperiod of<br> <br>2021	Increase/(decrease)			Main reasons
Net profit attributable to equity holders<br>of the Company (million)	31,117	48,486		-35.8	%	A decrease in investment income due to the increasing volatilities in equity market
Net profit attributable to equity holders<br>of the Company after deducting non-recurring items (million)	31,182	48,651		-35.9	%
Earnings per share (basic and diluted)<br>(RMB per share)	1.10	1.72		-35.8	%	A decrease in net profit attributable to equity holders of the Company in the first three quarters on a year-on-year basis
Weighted average ROE (%)	6.63	10.46		A<br>decrease<br>of 3.83<br>percentage<br>points

• 4 -

2.	INFORMATION ON SHAREHOLDERS

Total Number of Ordinary Share Shareholders and the Particulars of Top Ten Shareholders as at the End of the Reporting Period

Total number of shareholders asat the end of the Reporting Period	Number of A<br>Share shareholders: 115,291
	Number of H<br>Share shareholders: 25,069
Particulars of top ten shareholders of the Company										Unit: Share
Name of shareholders	Nature of<br><br><br>shareholder	Percentage<br><br><br>ofshareholding			Total number<br><br><br>of shares<br> <br>held as attheend of theReporting<br> <br>Period		Numberofshares subject<br> <br>to sellingrestrictions		Numberof sharespledged or<br><br><br>frozen
China Life Insurance<br>(Group) Company	State-owned legal person		68.37	%		19,323,530,000		–		–
HKSCC Nominees<br>Limited	Overseas legal person		25.92	%		7,326,220,781		–		–
China Securities Finance<br>Corporation Limited	State-owned legal person		2.51	%		708,240,246		–		–
Central Huijin Asset<br>Management Limited	State-owned legal person		0.41	%		117,165,585		–		–
Hong Kong Securities<br>Clearing Company Limited	Overseas legal person		0.13	%		35,649,120		–		–
Guosen Securities Co., Ltd.<br>– Founder Fubon CSI Insurance Theme Index Securities Investment Fund	Other		0.09	%		25,177,829		–		–
China Universal Asset<br>Management Co., Ltd – Industrial and Commercial Bank of China Limited – China Universal – Tianfu Bull No. 53 Asset Management Plan	Other		0.05	%		15,015,845		–		–
Industrial and Commercial<br>Bank of China Limited – SSE 50 Exchange Traded Index Securities Investment Fund	Other		0.05	%		14,757,904		–		–
Dajia Life Insurance Co.,<br>Ltd – Universal Products	Other		0.05	%		13,764,442		–		–
Li Zhuo	Domestic natural person		0.04	%		10,454,133		–		–

Notes:

1.	HKSCC Nominees Limited is a company that holds shares on behalf of the clients of the Hong Kong stock<br>brokers and other participants of the CCASS system. The relevant regulations of The Stock Exchange of Hong Kong Limited do not require such persons to declare whether their shareholdings are pledged or frozen. Hence, HKSCC Nominees Limited is unable<br>to calculate or provide the number of shares that are pledged or frozen.
2.	China Universal Asset Management Co., Ltd – Industrial and Commercial Bank of China Limited –<br>China Universal – Tianfu Bull No. 53 Asset Management Plan has Industrial and Commercial Bank of China Limited as its asset trustee. Industrial and Commercial Bank of China Limited – SSE 50 Exchange Traded Index Securities Investment<br>Fund has Industrial and Commercial Bank of China Limited as its fund depositary. Save as above, the Company was not aware of any connected relationship and concerted parties as defined by the “Measures for the Administration of the Takeover of<br>Listed Companies” among the top ten shareholders of the Company.
---	---

• 5 -

3.	QUARTERLY BUSINESS OVERVIEW

The first three quarters of 2022 witnessed complicated and ever-changing external environment. The domestic economy maintained the momentum of recovery and growth, and the life insurance industry was still at a stage of profound adjustments. The Company steadfastly pursued its development with Chinese characteristics and put into practice the core development philosophy of “due role of insurance in protection” and “people-centered insurance”. The Company effectively coordinated pandemic prevention and control as well as business development, took initiatives to serve and stabilize the overall economy, and steadily pushed forward all tasks according to the requirements for high-quality development, as a result of which its market leading position remained solidified. Firstly, the Company achieved stable business growth and its businessscale and value continued to lead the industry. In the first three quarters of 2022, the Company achieved revenues from insurance businesses1 of RMB554,105 million, an increase of 0.1% year on year. Premiums from new policies were RMB171,338 million, an increase of 6.3% year on year. First-year regular premiums amounted to RMB91,370 million, which remained stable as compared to the corresponding period last year. In particular, first-year regular premiums with a payment duration of ten years or longer were RMB38,694 million, an increase of 4.9% year on year. Short-term insurance premiums amounted to RMB67,066 million. Renewal premiums were RMB382,767 million. The value of new business for the first three quarters of 2022 decreased by 15.4% year on year. The surrender rate2 was 0.74%, a decrease of 0.19 percentage point year on year. Secondly, the quality of its sales force was enhanced with stabilized headcount. The Company continued to drive business development through productive agents, upheld the sales force strategy of “stabilizing headcount while seeking for higher productivity”, firmly promoted transformation and upgrade of sales force and the size of its sales force remained stabilized. It continuously enhanced the quality of its sales force, the foundation of which was strengthened as a whole. As at the end of the Reporting Period, the Company’s total sales force was 783,000, including 720,000 agents in the individual agent business sector. Thirdly, it coped with the complicated investment environment by taking various measures. As at 30 September 2022, the Company’s investment assets reached RMB4,923,484 million, an increase of 4.4% from the end of 2021. In the third quarter of 2022, the coupon rate of domestic bonds remained volatile at historic lows, which created a persistent pressure on the allocation of fixed-income assets. Continuous adjustments were seen in the stock market and the investment income from open market equity investment was still under pressure. The Company balanced short-term tactic adjustments and long-term investment deployments, and flexibly adjusted allocation and the type of fixed-income investment products in response to the interest rate and the market supply. For equity investment, it maintained reasonable positions and realized gains by seizing appropriate opportunities. In the first three quarters of 2022, the Company achieved the gross investment income^3^ of RMB142,565 million, and the gross investment yield^4^ was 4.03%. The net investment income^5^ was RMB145,686 million, an increase of 4.7% year on year, and the net investment yield^6^ was 4.12%. Fourthly, the solvency of the Company continued to stay at a higher level. The life insurance industry started to implement the “Solvency Regulatory Rules II for Insurance Companies” (the “C-ROSS (Phase II) Regulation”) from the solvency quarterly report for the first quarter 2022. Under the C-ROSS (Phase II) Regulation, as at the end of the Reporting Period, the core solvency ratio and the comprehensive solvency ratio of the Company were 161.93% and 230.26%, respectively. The Company has sufficient core capital and overall capital and its solvency continued to stay relatively high.

^1^	Revenues from insurance businesses is consistent with Premium Income in the attached consolidated income<br>statement.
^2^	Surrender Rate = Surrender payment/(Opening balance of life insurance reserves and long-term health<br>insurance reserves + Premiums from life insurance and long-term health insurance)
---	---

• 6 -

In the first three quarters of 2022, net profit attributable to equity holders of the Company was RMB31,117 million, a decrease of 35.8% year on year.

For the next stage, the Company will uphold the guideline of making progress while maintaining stability, adhere to the original function of insurance, consistently deepen supply-side reforms, give full play to the protection role of insurance, and strive to achieve steady business development. The Company will deepen reform and transformation with firm determination, strengthen the protection of consumers’ rights and interests in all aspects, and continue to pursue the high-quality development of the Company by enhancing its capability of value creation, digital operations, innovation of insurance products and services as well as risk prevention and control.

^3^	Gross investment income = Net investment income + Net realized gains on investment assets + Fair value<br>gains/losses Impairment losses of investment assets
^4^	Gross investment yield = [(Gross investment income – Interest paid for financial assets sold under<br>agreements to repurchase)/ ((Investment assets at the end of the previous year – Financial assets sold under agreements to repurchase at the end of the previous year + Investment assets at the end of the period – Financial assets sold<br>under agreements to repurchase at the end of the period)/2)]/273×365
---	---
^5^	Net investment income mainly includes interest income, dividend and bonus from different types of financial<br>assets, net income from investment properties, and share of profit of associates and joint ventures, etc.
---	---
^6^	Net investment yield = [(Net investment income – Interest paid for financial assets sold under<br>agreements to repurchase)/ ((Investment assets at the end of the previous year – Financial assets sold under agreements to repurchase at the end of the previous year + Investment assets at the end of the period – Financial assets sold<br>under agreements to repurchase at the end of the period)/2)]/273×365
---	---

• 7 -

4.	QUARTERLY FINANCIAL STATEMENTS

Balance sheet as at 30 September 2022 (unaudited)

RMB million (Unless otherwise stated)

	As at<br><br><br>30 September		As at<br><br><br>31 December		As at<br><br><br>30 September		As at<br><br><br>31 December
	2022		2021		2022		2021
ASSETS	Group		Group		Company		Company
Assets
Cash fund		121,213		60,875		94,338		53,591
Financial assets at fair value through profit or loss		214,014		206,764		99,457		120,184
Securities purchased under agreements to resell		26,179		12,915		14,970		3,463
Interest receivables		57,614		50,801		55,202		49,583
Premiums receivables		40,354		20,361		40,354		20,361
Receivables from reinsurers		1,496		485		1,496		485
Unearned premium reserves receivable from reinsurers		1,110		823		1,110		823
Claim reserves receivable from reinsurers		781		412		781		412
Reserves for life insurance receivables from reinsurers		786		636		786		636
Reserves for long-term health insurance receivables from reinsurers		4,427		4,274		4,427		4,274
Other receivables		17,874		25,667		14,346		21,347
Loans		589,602		666,087		572,271		646,998
Term deposits		499,754		529,488		457,348		491,332
Available-for-sale<br>financial assets		1,613,800		1,429,287		1,546,009		1,370,035
Held-to-maturity<br>investments		1,571,231		1,533,753		1,568,918		1,531,640
Long-term equity investments		268,320		257,953		449,328		385,723
Statutory deposits		6,333		6,333		5,653		5,653
Investment properties		13,038		13,374		6,046		6,191
Constructions in progress		5,938		6,789		5,334		6,350
Fixed assets		46,579		46,847		43,831		44,014
Right-of-use<br>assets		2,010		2,518		1,705		2,239
Intangible assets		8,396		8,409		7,428		7,599
Deferred tax assets		11,362		121		11,180		–
Other assets		5,867		6,104		5,460		5,760
Separate account assets		7		9		7		9
Total Assets	****	5,128,085	****	4,891,085	****	5,007,785	****	4,778,702
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 8 -

Balance sheet as at 30 September 2022 (unaudited) (continued)

RMB million (Unless otherwise stated)

	As at<br><br><br>30 September		As at<br><br><br>31 December		As at<br><br><br>30 September		As at<br><br><br>31 December
LIABILITIES AND EQUITY	2022<br><br><br>Group		2021<br><br><br>Group		2022<br><br><br>Company		2021<br><br><br>Company
Liabilities
Short-term borrowings		1,429		1,476		–		–
Financial liabilities at fair value through profit or loss		3,609		3,416		–		–
Securities sold under agreements to repurchase		87,816		239,446		75,162		232,496
Premiums received in advance		3,758		48,699		3,758		48,699
Brokerage and commission payable		4,746		5,352		4,746		5,351
Reinsurance payable		1,564		808		1,564		808
Salary and welfare payable		9,382		13,165		8,426		11,791
Taxes payable		1,075		967		683		435
Claims payable		60,128		56,818		60,128		56,818
Policyholder dividends payable		103,795		124,949		103,795		124,949
Other payable		23,137		18,953		21,029		16,540
Policyholder deposits		362,701		313,585		362,701		313,585
Unearned premium reserves		24,878		14,062		24,878		14,062
Claim reserves		28,351		26,234		28,351		26,234
Reserves for life insurance		3,568,050		3,182,083		3,568,050		3,182,083
Reserves for long-term health insurance		224,576		197,520		224,576		197,520
Long-term borrowings		18,183		17,210		–		–
Bonds payable		34,996		34,994		34,996		34,994
Lease liabilities		1,790		2,182		1,472		1,889
Deferred tax liabilities		545		7,481		–		6,481
Other liabilities		101,455		95,018		28,777		26,901
Separate account liabilities		7		9		7		9
Total liabilities	****	4,665,971	****	4,404,427	****	4,553,099	****	4,301,645
Equity<br><br><br>Share capital		28,265		28,265		28,265		28,265
Capital reserve		54,069		54,304		52,897		53,056
Accumulated other comprehensive income		12,583		50,299		10,989		49,489
Surplus reserve		101,228		96,132		101,180		96,084
General reserve		48,383		48,320		47,409		47,409
Retained earnings		208,918		201,265		213,946		202,754
Attributable to equity holders of the Company	****	453,446	****	478,585
Non-controlling interests	****	8,668	****	8,073
Total equity	****	462,114	****	486,658	****	454,686	****	477,057
Total liabilities and equity	****	5,128,085	****	4,891,085	****	5,007,785	****	4,778,702
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 9 -

Income statement for the third quarter of 2022 (unaudited)

RMB million (Unless otherwise stated)

		For the nine months						For the nine months
		ended 30 September						ended 30 September
ITEMS		2022<br><br><br>Group			2021<br><br><br>Group			2022<br><br><br>Company			2021<br><br><br>Company
					(Restated)
1	Operating income	****	701,012	****	****	727,785	****	****	699,558	****	****	720,292	****
	Premiums earned		536,679			536,368			536,679			536,368
	Premium income		554,105			553,437			554,105			553,437
	Including: Reinsurance premium<br>income		–			–			–			–
	Less: Premiums ceded to reinsurers		(6,897	)		(5,988	)		(6,897	)		(5,988	)
	Change in unearned<br>premium reserves		(10,529	)		(11,081	)		(10,529	)		(11,081	)
	Investment income		165,354			188,868			164,412			186,174
	Including: Share of profit of associates and joint<br>ventures		6,352			8,537			7,840			9,179
	Other gains		148			148			88			83
	Fair value gains/(losses)		(8,104	)		(4,625	)		(5,702	)		(5,327	)
	Foreign exchange gains/(losses)		214			361			1,020			(25	)
	Other operating income		6,651			6,634			2,991			2,988
	Gains/(losses) on disposal of assets		70			31			70			31
2	Operating expenses	****	(672,832	)	****	(676,718	)	****	(670,087	)	****	(673,041	)
	Surrenders		(28,693	)		(31,813	)		(28,693	)		(31,813	)
	Claims expenses		(107,736	)		(107,116	)		(107,736	)		(107,116	)
	Less: Claims recoverable from reinsurers		5,045			4,200			5,045			4,200
	Increase in insurance contracts reserve		(415,129	)		(398,933	)		(415,129	)		(398,933	)
	Less: Insurance reserves recoverable from reinsurers		672			849			672			849
	Policyholder dividends resulting from participation in<br>profits		(17,285	)		(22,277	)		(17,285	)		(22,277	)
	Tax and surcharges		(787	)		(945	)		(676	)		(826	)
	Underwriting and policy acquisition costs		(45,713	)		(54,422	)		(45,712	)		(54,388	)
	Administrative expenses		(28,615	)		(28,424	)		(26,492	)		(26,503	)
	Less: Expenses recoverable from reinsurers		1,050			741			1,050			741
	Other operating expenses		(20,866	)		(19,964	)		(19,828	)		(18,372	)
	Impairment losses		(14,775	)		(18,614	)		(15,303	)		(18,603	)
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 10 -

Income statement for the third quarter of 2022 (unaudited) (continued)

RMB million (Unless otherwise stated)

		For the nine months		For the nine months
		ended 30 September		ended 30 September
ITEMS		2022<br><br><br>Group	2021<br><br><br>Group	2022<br><br><br>Company			2021<br><br><br>Company
			(Restated)
3	Operating profit	28,180	51,067	****	29,471	****	****	47,251	****
	Add: Non-operating income	59	66		55			58
	Less: Non-operating expenses	(286)	(368)		(285	)		(368	)
4	Profit before income tax	27,953	50,765	****	29,241	****	****	46,941	****
	Less: Income tax expenses	4,315	(1,190)		5,369			(243	)
5	Net profit	32,268	49,575	****	34,610	****	****	46,698	****
	According to operating continuity:
	– Net profit from continuing operations	32,268	49,575		34,610			46,698
	According to ownership of the company:
	– Equity holders of the Company	31,117	48,486
	– Non-controlling interests	1,151	1,089
6	Earnings per share
	Basic earnings per share	RMB1.10	RMB1.72
	Diluted earnings per share	RMB1.10	RMB1.72
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 11 -

Income statement for the third quarter of 2022 (unaudited) (continued)

RMB million (Unless otherwise stated)

		For the nine months		For the nine months
		ended 30 September		ended 30 September
ITEMS		2022<br><br><br>Group	2021<br><br><br>Group	2022<br><br><br>Company			2021<br><br><br>Company
			(Restated)
7	Other Comprehensive income	(37,752)	(9,976)	****	(38,450	)	****	(10,282	)
	Other comprehensive income attributable to equity holders of the Company (net of tax)	(37,649)	(9,928)
	Other comprehensive income that may be reclassified to profit or loss	(37,473)	(9,650)		(38,188	)		(10,004	)
	Fair value gains/(losses) on<br>available-for-sale financial assets	(45,538)	5,437		(46,455	)		5,399
	Less: Amount transferred to net profit from other comprehensive income	(5,551)	(16,621)		(5,409	)		(16,495	)
	Portion of fair value changes on available-for- sale financial assets attributable to participating policyholders	14,691	1,109		14,691			1,109
	Other comprehensive income that may be transferred to profit or loss under the equity<br>method	(1,723)	565		(1,035	)		(55	)
	Exchanges differences on translating foreign operations	648	(140)		20			38
	Other comprehensive income that will not be reclassified to profit or loss	(176)	(278)		(262	)		(278	)
	Other comprehensive income that may not be transferred to profit or loss under the equity<br>method	(176)	(278)		(262	)		(278	)
	Other comprehensive income attributable to non-controlling interests (net of tax)	(103)	(48)
8	Total Comprehensive income	(5,484)	39,599	****	(3,840	)	****	36,416	****
	– Attributable to equity holders of the Company	(6,532)	38,558
	– Attributable to non-controlling interests	1,048	1,041
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 12 -

Cash flow statement for the third quarter of 2022 (unaudited)

RMB million (Unless otherwise stated)

		For the nine months		For the nine months
		ended 30 September		ended 30 September
ITEMS		2022<br><br><br>Group	2021<br><br><br>Group	2022<br><br><br>Company			2021<br><br><br>Company
			(Restated)
1	Cash flows from operating activities
	Premiums received	494,458	484,552		494,458			484,552
	Net increase in policyholder deposits	38,442	11,941		38,442			11,941
	Net cash received from financial assets at fair value<br><br><br>through profit or loss	–	297		15,414			13,974
	Net cash received from financial liabilities at fair value through profit or loss	1,865	–		–			–
	Cash received from other operating activities	12,902	9,667		7,492			4,684
	Sub-total of cash inflows from operatingactivities	547,667	506,457	****	555,806	****	****	515,151	****
	Cash paid for claims	(133,065)	(136,268)		(133,065	)		(136,268	)
	Net cash paid for reinsurance business	(1,057)	(1)		(1,057	)		(1	)
	Cash paid for brokerage and commission fees	(46,369)	(56,136)		(46,366	)		(56,081	)
	Cash paid for policyholder dividends	(17,803)	(19,305)		(17,803	)		(19,305	)
	Cash paid to and for employees	(20,183)	(18,333)		(18,510	)		(17,000	)
	Cash paid for taxes and surcharges	(5,481)	(13,665)		(3,477	)		(11,794	)
	Net cash paid for financial assets at fair value through profit or loss	(15,456)	–		–			–
	Net cash paid for financial liabilities at fair value through profit or loss	–	(425)		–			–
	Cash paid for other operating activities	(19,498)	(15,951)		(18,986	)		(15,589	)
	Sub-total of cash outflows from operatingactivities	(258,912)	(260,084)	****	(239,264	)	****	(256,038	)
	Net cash flows from operating activities	288,755	246,373	****	316,542	****	****	259,113	****
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 13 -

Cash flow statement for the third quarter of 2022 (unaudited)(continued)

	RMB million (Unless otherwise stated)
	For the nine months<br><br><br><br> <br>ended 30 September						For the nine months<br><br><br><br> <br>ended 30 September
ITEMS	2022<br> <br><br><br><br>Group			2021<br> <br><br><br><br>Group			2022<br> <br><br><br><br>Company			2021<br> <br><br><br><br>Company
				(Restated)
2   Cash flows from investing activities
Cash received from sales and redemption of investments		930,542			490,024			823,882			479,031
Cash received from investment income		134,495			121,431			131,863			119,247
Net cash received from disposals of fixed assets, intangible assets and other long-term<br>assets		148			247			147			65
Net cash received from securities purchased under agreements to resell		–			–			–			3,349
Net cash received from the disposal of subsidiaries and other business units		255			481			2,263			499
Sub-total of cash inflows from investingactivities	****	1,065,440	****	****	612,183	****	****	958,155	****	****	602,191	****
Cash paid for investments		(1,080,431	)		(862,858	)		(1,015,918	)		(867,859	)
Net increase in policy loans		(12,922	)		(26,828	)		(12,922	)		(26,828	)
Cash paid for acquisition of fixed assets, intangible assets and other long-term assets		(1,683	)		(3,107	)		(1,358	)		(2,837	)
Net cash paid from securities purchased under agreements to resell		(12,867	)		(7,684	)		(11,507	)		–
Net cash paid for the acquisition of subsidiaries and other business units		(12,117	)		(13,100	)		(12,513	)		(13,329	)
Sub-total of cash outflows from investingactivities	****	(1,120,020	)	****	(913,577	)	****	(1,054,218	)	****	(910,853	)
Net cash flows from investing activities	****	(54,580	)	****	(301,394	)	****	(96,063	)	****	(308,662	)
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 14 -

Cash flow statement for the third quarter of 2022 (unaudited) (continued)

		RMB million (Unless otherwise stated)
		For the nine months<br><br><br><br> <br>ended 30 September						For the nine months<br><br><br><br> <br>ended 30 September
ITEMS		2022<br> <br><br><br><br>Group			2021<br> <br><br><br><br>Group			2022<br> <br><br><br><br>Company			2021<br> <br><br><br><br>Company
					(Restated)
3	Cash flows from financing activities
	Cash received from investment		3,241			17,310			–			–
	Including: Cash received from the investment of non- controlling interests by<br>subsidiaries		3,241			17,310
	Net cash received for securities sold under agreements to repurchase		–			65,842			–			66,324
	Sub-total of cash inflowsfrom financing activities	****	3,241	****	****	83,152	****	****	–	****	****	66,324	****
	Cash repaid to lenders		(92	)		–			–			–
	Cash paid for dividends and interests and repaid for lenders		(24,409	)		(25,402	)		(21,825	)		(21,671	)
	Net cash paid for securities sold under agreements to repurchase		(151,849	)		–			(157,334	)		–
	Cash paid for other financing activities		(1,228	)		(1,855	)		(760	)		(995	)
	Sub-total of cash outflowsfrom financing activities	****	(177,578	)	****	(27,257	)	****	(179,919	)	****	(22,666	)
	Net cash flows from financing activities	****	(174,337	)	****	55,895	****	****	(179,919	)	****	43,658	****
4	Effect of changes in foreign exchange rate on cash and cash equivalents	****	228	****	****	(30	)	****	189	****	****	(21	)
5	Net increase in cash and cash equivalents	****	60,066	****	****	844	****	****	40,749	****	****	(5,912	)
	Add: Opening balance of cash and cash equivalents		60,440			56,655			53,593			50,692
6	Closing balance of cash and cash equivalents	****	120,506	****	****	57,499	****	****	94,342	****	****	44,780	****
Bai Tao	Huang Xiumei	Li Mingguang	Hu Jin
---	---	---	---
Legal Representative	Vice President in<br><br><br>charge of Accounting Affairs	Chief Actuary	Head of<br><br><br>Financial Department

• 15 -

This announcement is published in both Chinese and English. Should there be anyinconsistency between the Chinese and English versions, the Chinese version shall prevail.

By Order of the Board
China Life Insurance Company Limited<br><br><br>Heng Victor Ja Wei
Company Secretary

As at the date of this announcement, the Board of Directors of the Company comprises:

Executive Directors:	Bai Tao, Li Mingguang, Huang Xiumei
Non-executive Director:	Wang Junhui
Independent Non-executive Directors:	Lam Chi Kuen, Zhai Haitao, Huang Yiping, Chen Jie

Beijing, China

27 October 2022

• 16 -